Carson Wealth (CWM LLC)’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
21,464
+3,879
| +22% | +$29.3K | ﹤0.01% | 2355 |
|
|
2025
Q1 | $97K | Buy |
17,585
+15,549
| +764% | +$85.8K | ﹤0.01% | 2445 |
|
|
2024
Q4 | $12K | Buy |
2,036
+1,700
| +506% | +$10K | ﹤0.01% | 3748 |
|
|
2024
Q3 | $3K | Buy |
336
+32
| +11% | +$286 | ﹤0.01% | 4262 |
|
|
2024
Q2 | $4K | Buy |
304
+14
| +5% | +$184 | ﹤0.01% | 3943 |
|
|
2024
Q1 | $5K | Sell |
290
-36
| -11% | -$621 | ﹤0.01% | 3642 |
|
|
2023
Q4 | $3K | Sell |
326
-1,174
| -78% | -$10.8K | ﹤0.01% | 3680 |
|
|
2023
Q3 | $17K | Buy |
1,500
+1,200
| +400% | +$13.6K | ﹤0.01% | 2782 |
|
|
2023
Q2 | $6K | Buy |
300
+179
| +148% | +$3.58K | ﹤0.01% | 3334 |
|
|
2023
Q1 | $5K | Sell |
121
-19
| -14% | -$785 | ﹤0.01% | 3273 |
|
|
2022
Q4 | $7K | Buy |
140
+83
| +146% | +$4.15K | ﹤0.01% | 2990 |
|
|
2022
Q3 | $3K | Hold |
57
| – | – | ﹤0.01% | 3283 |
|
|
2022
Q2 | $3K | Buy |
57
+54
| +1,800% | +$2.84K | ﹤0.01% | 3179 |
|
|
2022
Q1 | $0 | Sell |
3
-4
| -57% | – | ﹤0.01% | 3591 |
|
|
2021
Q4 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 3270 |
|